{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:08Z","timestamp":1790957948217,"version":"4.1.0"},"reference-count":11,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s282058","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T20:48:05Z","timestamp":1623703685000},"page":"2519-2527","source":"Crossref","is-referenced-by-count":3,"title":["Stability of Aprepitant Injectable Emulsion in Alternate Infusion Bags, in Refrigerated Storage, and Admixed with Dexamethasone and Palonosetron"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Thomas","family":"Ottoboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Santhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6]]},"reference":[{"key":"ref1","unstructured":"NCCN clinical practice guidelines in oncology: antiemesis\u2015version 2.2020. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf. Accessed September 8, 2020."},{"key":"ref2","unstructured":"Heron Therapeutics. CinvantiTM (Aprepitant) Injectable Emulsion, for Intravenous Use [Prescribing Information]. San Diego, CA: Heron Therapeutics; 2019."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00520-016-3313-0","volume":"25","author":"Herrstedt","year":"2017","journal-title":"Supportive Care Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","volume":"35","author":"Hesketh","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00520-016-3365-1","volume":"25","author":"Roila","year":"2017","journal-title":"Supportive Care Cancer"},{"key":"ref6","unstructured":"ASHP and the University of Utah Drug Information Service. Small-volume parenteral solutions shortages suggestions for management and conservation. US Food and Drug Administration Web site: 2017. Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/DrugShortages\/UCM582461.pdf. Accessed September 8, 2020."},{"key":"ref7","unstructured":"US Food and Drug Administration. FDA Commissioner Scott Gottlieb, M.D, updates on some ongoing shortages related to IV fluids (2018 Jan 16). Available from: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm592617.htm. Accessed September 8, 2020."},{"key":"ref8","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Validation of analytical procedures: text and methodology Q2(R1). Available from: http:\/\/academy.gmp-compliance.org\/guidemgr\/files\/Q2(R1).PDF. Accessed September 8, 2020."},{"key":"ref9","unstructured":"Eisai Inc. Aloxi (Palonosetron HCl) Injection for Intravenous Use [Prescribing Information]. Woodcliff Lake, NJ, USA: Eisai Inc; 2020."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1211\/PJ.2015.20068289","volume":"25","author":"Bentley","year":"2015","journal-title":"Pharmaceut J"},{"key":"ref11","unstructured":"US Food and Drug Administration. FDA Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices. Available from: https:\/\/www.fda.gov\/media\/114001\/download. Accessed September 8, 2020."}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=70521","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=70521","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T20:48:16Z","timestamp":1623703696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/stability-of-aprepitant-injectable-emulsion-in-alternate-infusion-bags-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2147\/dddt.s282058","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}